Special Diversified Opportunities Inc  

(Public, OTCMKTS:SDOI)   Watch this stock  
Find more results for Kevin Ha
0.000 (0.00%)
Feb 8 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.83 - 1.23
Open     -
Vol / Avg. 0.00/14,126.00
Mkt cap 18.99M
P/E     -
Div/yield     -
EPS -0.05
Shares 21.03M
Beta 0.62
Inst. own 42%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -4.46% -4.88%
Return on average equity -4.54% -4.99%
Employees 1 -
CDP Score - -


1521 Concord Pike Ste 301
WILMINGTON, DE 19803-3644
United States - Map
+1-302-8247062 (Phone)
+1-302-6365454 (Fax)

Website links


Special Diversified Opportunities Inc. is a shell company. Prior to the completion of the asset sale, the Company was a biotechnology company, is engaged in developing, commercializing and marketing products, services and solutions that preserve and enhance the human health and wellness. The Company supplied products custom services and critical reagents used across the life science research and development markets. The Company's Genomic Antibody Technology (GAT) was used in proteomic research disease understanding and drug/biomarker discovery among academic, biotech, in-vitro diagnostic and pharmaceutical customers.

Officers and directors

Philip Thomas Blazek President
Age: 47
Kevin J. Bratton Chief Financial Officer, Vice President - Finance, Corporate Secretary
Age: 66
Gregory H A Baxter Director
Age: 61
Thomas J. Kelleher Director
Kenneth Young Director
David M. Wurzer CPA Independent Director
Age: 56
Wayne P. Yetter Independent Director
Age: 70